These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7639087

  • 1. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
    Wahlund B, Sääf J, Wetterberg L.
    Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087
    [Abstract] [Full Text] [Related]

  • 2. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
    Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ.
    Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
    [Abstract] [Full Text] [Related]

  • 3. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G, Rihmer Z, Frecska E, Szádóczky E, Arató M.
    Psychoneuroendocrinology; 1986 Jun; 11(1):117-20. PubMed ID: 3704065
    [Abstract] [Full Text] [Related]

  • 4. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
    Meltzer HY, Lowy MT, Locascio JJ.
    Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
    [Abstract] [Full Text] [Related]

  • 5. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ.
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [Abstract] [Full Text] [Related]

  • 6. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN, Sharma RP, Janicak PG, Davis JM.
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [Abstract] [Full Text] [Related]

  • 7. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
    Bloomingdale KL, Vasile RG, Gudeman JE, Gerson B, Schildkraut JJ.
    Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
    [No Abstract] [Full Text] [Related]

  • 8. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study.
    Maj M, Ariano MG, Arena F, Kemali D.
    Neuropsychobiology; 1984 Apr; 11(3):168-73. PubMed ID: 6089030
    [Abstract] [Full Text] [Related]

  • 9. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT, Marciniak R.
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [Abstract] [Full Text] [Related]

  • 10. Platelet MAO activity in clinical subtypes of depression and DST suppression.
    Poirier MF, Lôo H, Mitrani N, Benkelfat C, Askienazy S, Le Fur G.
    Acta Psychiatr Scand; 1987 May; 75(5):456-63. PubMed ID: 3604729
    [Abstract] [Full Text] [Related]

  • 11. Affective disorder subtyped by psychomotor symptoms, monoamine oxidase, melatonin and cortisol: identification of patients with latent bipolar disorder.
    Wahlund B, Grahn H, Sääf J, Wetterberg L.
    Eur Arch Psychiatry Clin Neurosci; 1998 May; 248(5):215-24. PubMed ID: 9840367
    [Abstract] [Full Text] [Related]

  • 12. Clinical symptoms and platelet monoamine oxidase in subgroups and different states of affective disorders.
    Wahlund B, Sääf J, Wetterberg L.
    J Affect Disord; 1995 Oct 09; 35(1-2):75-87. PubMed ID: 8557890
    [Abstract] [Full Text] [Related]

  • 13. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
    Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO.
    Psychiatry Res; 1987 Feb 09; 20(2):155-64. PubMed ID: 3575560
    [Abstract] [Full Text] [Related]

  • 14. Increased platelet monoamine oxidase activity in affective disorders.
    Reveley MA, Glover V, Sandler M, Coppen A.
    Psychopharmacology (Berl); 1981 Feb 09; 73(3):257-60. PubMed ID: 6787645
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic subgrouping of depressed patients by principal component analysis and visualized pattern recognition.
    Wahlund B, Sääf J, Grahn H, Wetterberg L.
    Psychiatry Res; 1998 Dec 14; 81(3):393-401. PubMed ID: 9925191
    [Abstract] [Full Text] [Related]

  • 16. Relationship of platelet MAO activity to characteristics of major depressive illness.
    Georgotas A, McCue RE, Friedman E, Hapworth WE, Kim OM, Cooper TB, Chang I, Stokes PE.
    Psychiatry Res; 1986 Dec 14; 19(4):247-56. PubMed ID: 3809323
    [Abstract] [Full Text] [Related]

  • 17. Melatonin in psychiatric disorders - subtyping affective disorder.
    Wahlund B.
    Biol Signals Recept; 1999 Dec 14; 8(1-2):120-5. PubMed ID: 10085473
    [Abstract] [Full Text] [Related]

  • 18. Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test.
    Ravindran AV, Bialik RJ, Lapierre YD.
    J Affect Disord; 1994 Jun 14; 31(2):111-7. PubMed ID: 8071473
    [Abstract] [Full Text] [Related]

  • 19. Platelet monoamine oxidase in affective disorders.
    Edwards DJ, Spiker DG, Kupfer DJ, Foster G, Neil JF, Abrams L.
    Arch Gen Psychiatry; 1978 Dec 14; 35(12):1443-6. PubMed ID: 727880
    [Abstract] [Full Text] [Related]

  • 20. Altered platelet monoamine oxidase activity in affective disorders.
    Mann J.
    Psychol Med; 1979 Nov 14; 9(4):729-36. PubMed ID: 515270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.